SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 3 — Focused Visit (Care-plan review) — Richard Roundtree

PatientRichard Roundtree
Date of birth1975-07-09
IdentifiersMRN HR-ML015-SYN; SSN (made up) 000-15-8410
Document date2026-10-20
AuthorLeon Carrington, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Review two weeks after left breast cancer surgery. [S]

History of Present Illness

Mr. Roundtree returns thirteen days after mastectomy with level I and II axillary dissection for left breast cancer. He went home the next day. The drain was removed on the eighth day, and the wound has healed without infection or fluid. He took acetaminophen for the first ten days and needs nothing now. He has numbness under the left arm, as he was warned, and some tightness when he lifts the arm, which is improving with the exercises. He has no arm swelling. The pathology shows a 1.6 cm grade 3 invasive ductal carcinoma with clear margins, and 2 of 15 lymph nodes involved, the largest 7 mm, with no spread through the node capsule: stage IIA (pT1c pN1a). He saw medical oncology four days ago. They advised doxorubicin and cyclophosphamide every three weeks for four cycles, then weekly paclitaxel for twelve weeks, about six months in all, starting in about two weeks, then tamoxifen for at least five years, and a radiation oncology review after chemotherapy. An echocardiogram is booked this week. The germline result is not back. He feels low at times and worries about losing his hair and about work, but he is sleeping and eating. [S]

ElementDetail
SurgeryMastectomy and axillary dissection thirteen days ago; drain out; wound healed
PathologypT1c pN1a, grade 3, margins clear; stage IIA
ArmNumbness under the arm; tightness improving; no swelling
Plan from oncologyAbout six months of chemotherapy, then tamoxifen; radiation oncology review afterwards
MoodLow at times; PHQ-9 score 6

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo fever; appetite good
IntegumentaryNegativeWound healed; no redness or discharge
MusculoskeletalPositiveTightness at the end of left shoulder movement
NeurologicalPositiveNumbness under the left arm
CardiovascularNegativeNo chest pain, palpitations, or breathlessness on exertion
PsychiatricPositiveLow at times; PHQ-9 score 6; no thoughts of self-harm

6 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Acetaminophen 500 mg oral tablet, two tablets by mouth every 6 hours as needed for pain after surgery, no more than 3 g a dayTwo tablets every 6 hours as neededOral route2026-10-07 to 2026-10-17completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-10-20Body height188cmS
2026-10-20Body weight84.8kgS
2026-10-20Body mass index (BMI) [Ratio]24kg/m2S
2026-10-20Systolic blood pressure126mm[Hg]S
2026-10-20Diastolic blood pressure78mm[Hg]S
2026-10-20Heart rate76/minS
2026-10-20Respiratory rate14/minS
2026-10-20Body temperature36.7CelS
2026-10-20Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-10-20Hemoglobin [Mass/volume] in Blood13.9g/dL13.2-16.6 g/dLNormalS
2026-10-20Leukocytes [#/volume] in Blood by Automated count710*3/uL4-11 10*3/uLNormalS
2026-10-20Neutrophils [#/volume] in Blood by Automated count4.310*3/uL1.5-7.7 10*3/uLNormalS
2026-10-20Platelets [#/volume] in Blood by Automated count28110*3/uL150-400 10*3/uLNormalS
2026-10-20Creatinine [Mass/volume] in Serum or Plasma0.98mg/dL0.74-1.35 mg/dLNormalS
2026-10-20Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M93mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-10-20Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma21U/L7-55 U/LNormalS
2026-10-20Bilirubin.total [Mass/volume] in Serum or Plasma0.6mg/dL0.1-1.2 mg/dLNormalS
2026-10-20Albumin [Mass/volume] in Serum or Plasma4.3g/dL3.5-5 g/dLNormalS
2026-10-20Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]6{score}S

Physical Exam

Vital signs recorded on 2026-10-20; see the Vital Signs section. [S]

SystemFinding
GeneralWell
Chest wallLeft mastectomy scar healed; no seroma, redness, or nodule; drain site healed
Lymph nodesLeft axillary scar healed; no nodes on either side
MusculoskeletalLeft shoulder flexion 150 degrees and abduction 130 degrees
NeurologicalReduced light touch over the inner left upper arm and armpit; strength normal
ExtremitiesUpper arm circumference 33.5 cm on both sides, 15 cm below the shoulder tip; no swelling of the left hand or forearm

Problems

ProblemClinical statusVerificationCodeProvenance
Invasive ductal carcinoma of the left male breast, central (retroareolar) portion, presenting as a 1.5 cm firm, painless lump eccentric to the left nipple with a palpable left axillary node; core biopsy: grade 3, ER positive, PR positive, HER2 negative, with metastatic carcinoma in the node; clinical stage IIA (cT1c cN1 M0); synthetic modern detail linked to his publicly disclosed breast canceractiveconfirmed C50.122S — Synthetic size, grade, receptor status, and stage; the left-sided lump, the operation, and the spread to lymph nodes are from his public account (D).
Estrogen receptor-positive status of the breast canceractiveconfirmed Z17.0S — Synthetic receptor result; his tumor biology was not made public.
New firm, painless lump of about 1.5 cm just off the left nipple, with a palpable left axillary node; suspected breast cancer, imaging and core biopsy bookedresolvedconfirmed N63.42S — Synthetic presenting concern at the index visit, superseded by the biopsy diagnosis; the left-sided lump is from his public account (D).

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
LaboratoryBlood count before chemotherapyBefore cycle 1 and each cycle (oncology)Completed todayHemoglobin 13.9 g/dL, white cells 7.0, neutrophils 4.3, platelets 281
LaboratoryKidney and liver function before chemotherapyBefore cycle 1 (oncology)Completed todayCreatinine 0.98 mg/dL, eGFR 93; ALT 21 U/L, bilirubin 0.6 mg/dL, albumin 4.3 g/dL
ImagingEchocardiogram with ejection fraction before anthracyclineBaseline before doxorubicinOrderedBooked this week
LaboratoryHepatitis B screening before chemotherapyBefore the first cycleDueTo be drawn at the preventive visit next week
LaboratoryGermline multigene panel testingOnce, for every man with breast cancerOrderedSent fifteen days ago; result not yet back
ExaminationWound and shoulder movement after axillary surgeryEach visit after surgeryCompleted todayHealed; flexion 150 degrees, improving
ExaminationLymphedema assessment and risk-reduction counselingEvery visit after axillary surgeryCompleted todayUpper arm circumference 33.5 cm on both sides; skin care, avoiding tight sleeves on the left arm, and early reporting of swelling taught
ExaminationBaseline arm circumference missed before surgeryOnce, before axillary surgeryDeferredNot measured before the operation, a deviation from the protocol. Measured today at thirteen days, before any swelling, and equal on both sides; the right arm serves as the reference. No harm is evident, and future measurements will be compared with today's
SurveyDistress and depression screen (PHQ-9)Each visitCompleted todayPHQ-9 score 6, mild; no thoughts of self-harm; peer support and counseling offered
Medication safetyTamoxifen safety (clot symptoms, mood, hot flashes, sexual side effects, adherence)Every visit once tamoxifen startsNot indicatedTamoxifen starts after chemotherapy
ImagingMammographyYearly only for a breast treated by lumpectomy, or the other breast with a predisposing variantNot indicatedNo breast was treated by lumpectomy. Imaging of the other side is considered only with a predisposing variant, and the germline result is pending
Self-managementPhysical activityEvery visitCompleted todayWalking daily; gym work for the legs; no heavy lifting with the left arm for another two weeks

Goal progress:

Guideline basis: Hassett MJ, et al. Management of Male Breast Cancer: ASCO Guideline. J Clin Oncol 2020;38(16):1849-1863 (2020); NCCN Clinical Practice Guidelines in Oncology: Breast Cancer, Version 5.2025 (2025); Armenian SH, et al. Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: ASCO Clinical Practice Guideline. J Clin Oncol 2017;35(8):893-911 (2017); Hwang JP, et al. Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update. J Clin Oncol 2020 (2020); CMID: Clinical Monitoring Intelligence Database, breast cancer monograph (2026)

Follow-up: Echocardiogram this week. Preventive visit next week. Chemotherapy in about two weeks with medical oncology. Primary care review during chemotherapy. Next scheduled visit 2026-10-27: periodic adult preventive visit before chemotherapy. [S]